Navigation Links
Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
Date:8/11/2009

enosumab twice-yearly experienced a 68 percent reduction in the risk of suffering a vertebral (spine) fracture compared to those receiving placebo as well as a 40 percent reduction in the risk of suffering a hip fracture and a 20 percent reduction in the risk of suffering a nonvertebral fracture. Over the three years of this multi-center, randomized, double-blind, placebo-controlled study, women treated with denosumab experienced significant increases in BMD (8.8 percent at the lumbar spine and 6.4 percent at the total hip).(1)

"These results suggest that denosumab offers a new approach to prevention of fractures in women with postmenopausal osteoporosis," said Steven Cummings M.D., lead investigator, study author, and director of the San Francisco Coordinating Center of the California Pacific Medical Center Research Institute. "It reduces the risk of all major types of fractures and, because it is given as an injection twice a year, it also has the potential to help compliance to treatment."

Fracture is one of the most common health events suffered by postmenopausal women with osteoporosis.(3) Globally, one woman in three over 50 years of age will experience a fracture in her lifetime.(3) A woman who has broken a bone as a result of osteoporosis has more than an eight- out-of-ten chance of breaking another bone.(4) Half of women who break a hip, a life changing event, will permanently need assistance to walk.(5)

The overall incidence and type of side effects with denosumab were similar to placebo in the FREEDOM study. Rates of adverse events (AEs) were similar in both groups (93 percent). Rates of serious AEs were 25.8 percent for denosumab and 25.1 percent for placebo. The most common AEs across both treatment arms were arthralgia, back pain, hypertension and nasopharyngitis. There were no reported cases of osteonecrosis of the jaw among patients taking denosumab. Serious adverse events of skin infections,
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
8. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
9. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
10. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
11. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Serving a region of 650,000 ... , Caribbean Imaging and Radiation Therapy (CIRT, ... capabilities with the acquisition of an Elekta Versa HD™ system, ... HD offers clinicians the versatility to deliver conventional therapies to ... also enabling treatment of highly complex cancers that require extreme ...
(Date:5/17/2013)... N.J. , May 17, 2013  PENTAX ... and Hitachi-Aloka Medical, a global leader in ultrasound ... two global companies to enable further innovation in ... years, the Hitachi-Aloka ultrasound systems and PENTAX Medical ... most trusted families of EUS systems. This agreement ...
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... 2, 2011 Bionovo, Inc. (NASDAQ: BNVI ), ... safe and effective treatments for women,s health and cancer, today ... clinical trial of their lead drug candidate for postmenopausal symptoms, ... community at the 13th Annual World Congress on Menopause in ...
... 2011 / PRNewswire / -- Cadence Pharmaceuticals, ... focused on in-licensing, developing and commercializing proprietary products principally ... the company,s President and CEO Ted Schroeder will present ... at 1:30pm Eastern Time (10:30am Pacific Time) during the ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
(Date:5/19/2013)... Dalla, TX (PRWEB) May 19, 2013 ... comprehensive analysis for US, UK, Spain, Japan, Italy, ... pertaining to the molecular diagnostics laboratory practice, as ... technological trends with significant market impact during the ... of DNA probe and biochip technologies, test formats, ...
(Date:5/19/2013)... NY (PRWEB) May 19, 2013 Americans ... According to the newest American Veterinary Medical Association (AVMA) ... of American dog owners consider their dog a member ... who had said as much five years earlier. , ... dollar value of the national income dedicated to pets ...
(Date:5/19/2013)... 19, 2013 Vegas Hotel Escapes, the ... to announce the launch it's all new vacation packages ... Grand on 5/19/2013. Consumers traveling to Las Vegas will ... available on VegasHotelEscapes.com's website. Travelers will be pleased to ... competitors price. , Vegas Hotel Escapes specializes in helping ...
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... Universal Capital,Management, Inc. (OTC Bulletin Board: UCMT.OB), ... management and strategic growth,resources to emerging growth ... of its,holdings, iVolution Medical Systems, Inc. will ... to fruition. , ...
... Schizophrenia could be caused by faulty signalling in the ... journal Molecular Psychiatry . In the biggest study ... samples donated by people with the condition have identified ... schizophrenia patients compared to controls. , Many of these ...
... Company, Inc.,s new ,Feel Good, Light Lenses are perfect decorating pieces ... economical time. , ... (PRWEB) March 3, 2009 -- ... nation, the Flag Company, Inc. recently launched ,Feel Good, Light Lenses ...
... Bingo tickets for the Cystic Fibrosis Trust and raised over £10,000 for ... ... -- JackpotCity.com Online Bingo has ensured that both the Cystic Fibrosis Trust ... fight against this life-threatening disease. , , , , ,For over 40 ...
... Guinea The southeast Pacific nation of Papua ... diverse ecosystems on Earth, has created its first national ... tropical forest larger than Singapore. , The decision by ... local communities neighboring the newly established YUS Conservation Area, ...
... the flu vaccine and flu vaccine supplies has unveiled their annual 2009 ... , ... (Vocus) March 2, 2009 -- Nationwide Medical/Surgical , a distributor ... 2009 list of what to do if exposed to the flu virus., ...
Cached Medicine News:Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 2Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 3Health News:Schizophrenia linked to signaling problems in new brain study 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:JackpotCity.com Online Bingo Raises Over 10,000 for Cystic Fibrosis Trust 2Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4Health News:Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus 2
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: